{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:52:51Z","timestamp":1759341171958,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.revmed.2003.08.007","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T03:27:44Z","timestamp":1065842864000},"page":"111-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["\u00c9tude de l'influence d'une hypergammaglobulin\u00e9mie sur le titre des anticorps antiphospholipides"],"prefix":"10.1016","volume":"25","author":[{"given":"M","family":"Lambert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-L","family":"Fauchais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Dubucquoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Launay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Prin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-Y","family":"Hatron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Devulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2003.08.007_BIB1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1529-0131(200002)43:2<440::AID-ANR26>3.0.CO;2-N","article-title":"Validation of the Sapporo criteria for antiphospholipid syndrome","volume":"43","author":"Lockshin","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2003.08.007_BIB2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0038-1648840","article-title":"Prevalence, follow-up and clinical significance of the anticardiolipin in normal subjects","volume":"72","author":"Vila","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2003.08.007_BIB3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of the Antiphospholipid Antibody Syndrome","volume":"15","author":"Petri","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2003.08.007_BIB4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-0037-1614556","article-title":"The risk of thrombosis in patients with lupus anticoagulant is predicted by their specific coagulation profile","volume":"81","author":"Galli","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2003.08.007_BIB5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.1780330406","article-title":"Characteristics of high titer IgG antiphospholipid antibody in systemic lupus patients with and without f\u0153tal death","volume":"33","author":"Qamar","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2003.08.007_BIB6","first-page":"91","article-title":"Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study","volume":"26","author":"De Bandt","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2003.08.007_BIB7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","article-title":"Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70\u00a0patients","volume":"117","author":"Rosove","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2003.08.007_BIB8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: an inception-cohort prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2003.08.007_BIB9","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJM198605223142118","article-title":"Anticardiolipin antibodies in pregnant patients with systemic lupus erythematosus (letter)","volume":"314","author":"Lenzi","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2003.08.007_BIB10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/anr.1780320627","article-title":"Hypergammaglobulinemia and the anticardiolipin test","volume":"32","author":"Hughes","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2003.08.007_BIB11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/41.8.924","article-title":"A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome","volume":"41","author":"Erkan","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2003.08.007_BIB12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant \/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2003.08.007_BIB13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00005792-197103000-00001","article-title":"The natural history of systemic lupus erythematosus by prospective analysis","volume":"50","author":"Estes","year":"1971","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2003.08.007_BIB14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1055\/s-0038-1650686","article-title":"Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus","volume":"76","author":"Horbach","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2003.08.007_BIB15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ajcp\/101.4.471","article-title":"Incidence of antiphospholipid antibodies in patients with monoclonal gammapathy of undetermined significance","volume":"101","author":"Stern","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.revmed.2003.08.007_BIB16","first-page":"103","article-title":"Anti-hepatitis C virus antibodies in primary Sjogren's syndrome: false positive results are related to hypergammaglobulinemia","volume":"10","author":"Vitali","year":"1992","journal-title":"Clin Exp Rheumatol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866303003102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866303003102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:06:52Z","timestamp":1759334812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866303003102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0248866303003102"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2003.08.007","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tude de l'influence d'une hypergammaglobulin\u00e9mie sur le titre des anticorps antiphospholipides","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2003.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 \u00c9ditions scientifiques et m\u00e9dicales Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}